Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering. The company listed 5,175,000 units at 58 cents each.
Bone Biologics, a company focused on spine fusion products, announced a $2 million public offering. The public offering includes 781,251 shares of its common stock for $2.56 per share.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
